-

Rockwell Medical to Exhibit at ASN Kidney Week 2025

WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company is exhibiting its hemodialysis concentrates portfolio in Booth #316 at the American Society of Nephrology ("ASN") Kidney Week 2025, which will be held November 6-9 at the George R. Brown Convention Center in Houston, Texas.

Visit @RockwellMedical $RMTI in Booth #316 at @asnkidney #ASN2025 #KidneyWk @GRBCC #houstontx #hemodialysis

Share

Rockwell's hemodialysis concentrates portfolio includes:

  • CitraPure® Citric Acid Concentrate — Rockwell Medical's CitraPure concentrate is citric acid-based and 100% acetate-free. CitraPure is packaged as a liquid acid concentrate in 55-gallon drums and one-gallon jugs sold in cases of four. CitraPure is also packaged as a dry powder acid concentrate to be used exclusively with Rockwell Medical's Dry Acid Concentrate Mixer. Each case of dry product produces 25 gallons of liquid acid concentrate.
  • Dri-Sate® Acid Concentrate — Rockwell Medical's Dri-Sate concentrate is an acetic acid-based product. Dri-Sate is packaged as a dry powder acetic acid concentrate to be used exclusively with Rockwell Medical's Dry Acid Concentrate Mixer. Each case of Dri-Sate dry product produces 25 gallons of liquid acetic acid concentrate.
  • RenalPure® Acid Concentrate — Rockwell Medical's RenalPure concentrate is an acetic acid-based product. RenalPure is packaged as a liquid acid concentrate in 55-gallon drums and in one-gallon jugs sold in cases of two and four.
  • RenalPure® Bicarbonate Concentrate — Rockwell Medical's RenalPure bicarbonate concentrate is a dry powder mixed on-site at the clinic and is packaged in bulk and individual treatment sizes.
  • SteriLyte® Bicarbonate Concentrate — Rockwell Medical's SteriLyte bicarbonate is a liquid packaged in one-gallon jugs, sold in cases of two and four, and is mainly used in acute care settings.
  • Bicarbonate Cartridge — Rockwell Medical is distributing a 510(k) approved, premium grade, single-use bicarbonate cartridge in two sizes, 720g and 900g. Performance testing and risk analysis demonstrate that this device can be safely used on hemodialysis systems with compatible bicarbonate cartridge holder assemblies that meet the fit specifications of these cartridges.
  • Dry Acid Concentrate Mixer — Rockwell Medical's dry acid concentrate mixer is designed exclusively for the Company's CitraPure and Dri-Sate Dry Acid products and enables the clinic to mix acid concentrate on-site. Rockwell Medical's dry acid concentrate mixer is fast, compact, and easy to use. Clinics that use Rockwell Medical's dry acid concentrate products realize numerous advantages including lower cost per treatment, reduced storage space requirements, reduced number of deliveries, and more flexibility in scheduling deliveries.
  • Concentrates Cleaner and Salt Pellets — Rockwell Medical offers essential concentrates accessories including cleaning agents, 5% acetic acid cleaning solution, 5% and 2% dry citric acid descale, filtration salts, and other supplies used by hemodialysis providers.

More information about Rockwell Medical's hemodialysis concentrates product portfolio can be found on the Company's website: www.rockwellmed.com/hemodialysis-products.

About Rockwell Medical

Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is to provide dialysis clinics and the patients they serve with the highest quality products supported by the best customer service in the industry. Rockwell is focused on innovative, long-term growth strategies that enhance its products, its processes, and its people, enabling the Company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients. Hemodialysis is the most common form of end-stage kidney disease treatment and is typically performed in freestanding outpatient dialysis centers, hospital-based outpatient centers, skilled nursing facilities, or a patient’s home. Rockwell Medical's products are vital to vulnerable patients with end-stage kidney disease, and the Company is relentless in providing unmatched reliability and customer service. Certified as a Great Place to Work® in 2023, 2024 and 2025, and named Fortune Best Workplaces in Manufacturing & Production™ in 2024 and 2025, Rockwell Medical is Driven to Deliver Life-Sustaining Dialysis Solutions™. For more information, visit www.rockwellmed.com.

Contacts

Heather R. Hunter
(248) 432-1362
IR@RockwellMed.com

Rockwell Medical

NASDAQ:RMTI
Details
Headquarters: Wixom, MI
CEO: Mark Strobeck
Employees: 250
Organization: PUB
Revenues: 83,600,000 (2023)

Release Summary
Come visit Rockwell Medical in Booth #316 at ASN Kidney Week 2025 in Houston, TX.
Release Versions
$Cashtags

Contacts

Heather R. Hunter
(248) 432-1362
IR@RockwellMed.com

Social Media Profiles
More News From Rockwell Medical

Rockwell Medical Appoints Joe Dawson to the Company's Board of Directors

WIXOM, Mich.--(BUSINESS WIRE)--Joe Dawson is a seasoned executive who has extensive operational experience and a strong network in the renal care space....

Rockwell Medical Announces Third Quarter 2025 Results

WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical achieved profitability on an Adjusted EBITDA basis for the third quarter 2025....

Rockwell Medical Names Rashad Brown Vice President, Manufacturing and Supply Chain

WIXOM, Mich.--(BUSINESS WIRE)--Mr. Brown has built a distinguished career leading complex manufacturing and supply chain organizations....
Back to Newsroom